Novartis passes on $550M option to buy Proteon Therapeutics

Swiss pharmaceutical company Novartis AG has declined to exercise a $550 million option agreement to purchase Proteon Therapeutics Inc...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.